CSIMarket
 
Amgen Inc   (AMGN)
Other Ticker:  
 
 

Amgen Inc Growth Comparisons

Select each growth Category to receive further Information



AMGN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 19.84 % 13.05 % -4.14 % 3.77 %
Q / Q Revenue Growth (Q4 MRQ) 18.73 % 10.92 % - 4.61 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 7.09 % 5.41 % - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) 5.06 % 3.29 % - 1.16 %
Revenue 5 Year Average Growth 3.49 % 2.27 % 7.39 % 8.15 %


AMGN's Growth Comparisons in IV. Quarter 2023




Amgen Inc improved it's Revenue by 19.84% year on year in the forth quarter 2023, and outpaced the 13.05% rise in the Biotechnology & Pharmaceuticals industry, and -4.14% decrease in the Healthcare sector. Comparing the forth quarter sales growth, both Biotechnology & Pharmaceuticals industry and Amgen Inc outperformed 3.77% overall market increase.

Top-line improved by 18.73% from the third quarter. Looking into annual sales rise of 3.49%, and S & P 500's average yearly sales growth is 8.15% over the five years, including only Businesses with the forth quarter 2023 Results. Amgen Inc grew less than the market.


Growth Rates of AMGN's Income in the forth quarter 2023


AMGN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -43 % -31.74 % -34.08 % 1.59 %
Seq. Operating Income Change (Q4 MRQ) -37.11 % -10.34 % 20.29 % 11.84 %
Y / Y Operating Income Growth (Q4 TTM) -17.45 % -25.06 % -25.69 % 0.02 %
Seq. Operating Income Growth (Q4 TTM) -10.83 % -8.62 % -11.31 % 0.56 %
Operating Income 5 Year Avg. Change -5.11 % -9.44 % 3.09 % 8.56 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) -52.54 % -39.53 % 62.95 % 30.72 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) -55.66 % -24.16 % 82.3 % -5.63 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 2.52 % -15.39 % 14.83 % 8.52 %
Seq. Income from Cont. Ops. Change (Q4 TTM) -11.22 % -9.16 % 41.59 % 6.93 %
Income from Cont. Ops. 5 Year Avg. Change -4.36 % -9.52 % 0.8 % 8.41 %

AMGN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) -52.54 % -39.53 % 65.13 % 25.14 %
Q / Q Net Income Growth (Q4 MRQ) -55.66 % -24.16 % -37.09 % -16.26 %
Y / Y Net Income Change (Q4 TTM) 2.52 % -15.39 % 63.55 % 12.95 %
Seq. Net Income Change (Q4 TTM) -11.22 % -9.16 % 26.57 % 5.62 %
Net Income 5 Year Avg. Growth -4.36 % -9.52 % 6.11 % 9 %

AMGN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) -52.75 % -44.17 % 62.95 % 30.72 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) -55.73 % -28.89 % 82.3 % -5.63 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) 3.07 % -55.93 % - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) -11.28 % -16.39 % - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth -0.22 % -11.12 % 0.8 % 8.41 %



AMGN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) -52.98 % -44.17 % 65.13 % 8.41 %
Q / Q EPS Net Growth (Q4 MRQ) -55.81 % -28.89 % -37.09 % -16.26 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - -52.59 % - 127799.22 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) -11.37 % -15.86 % - 0 %
EPS Net 5 Year Avg. Change -0.21 % -9.52 % 6.11 % 9 %



As Amgen Inc 's income per share faded by -52.98% year on year in the forth quarter, Biotechnology & Pharmaceuticals industry fell only by -44.17%, Amgen Inc 's forth quarter performance was trailing Biotechnology & Pharmaceuticals, and underperformed the 65.13% EPS rise in the Healthcare sector. Healthcare sector grew above market average, while Biotechnology & Pharmaceuticals industry and Amgen Inc results underperformed, in the forth quarter.

Bottom-line fell by -55.81% from the third quarter results. Comparing the annual growth, income per share of -0.21% on average in last five years, to the S & P 500's, including only Businesses with the forth quarter 2023 earnings, average yearly income per share growth is 9%. Amgen Inc grew less than the market.

AMGN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) -79.69 % -73.11 % 11.42 % 0.32 %
Seq. Free Cash Flow Change (Q4 MRQ) -80.51 % -80.45 % -4.8 % 5.78 %
Y / Y Free Cash Flow Change (Q4 TTM) -12.86 % -5.66 % 5.42 % 1.53 %
Seq. Free Cash Flow Change (Q4 TTM) -19.95 % -12.19 % 1.71 % 6.83 %
Free Cash Flow 5 Year Avg. Change -6.96 % -9.51 % 13.61 % 8.83 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -
Seq. Net Cash Flow Change (Q4 MRQ) - - - 1270.07 %
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Seq. Net Cash Flow Change (Q4 TTM) - -97.39 % -56.97 % -
Net Cash Flow 5 Year Avg. Change 1.06 % -30.66 % 14.44 % 70.14 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -26.76 % -3.38 % 2.06 % -29.53 %
Seq. Capital Expenditures Change (Q4 MRQ) 0.4 % -5.27 % 17.68 % -5.26 %
Y / Y Capital Expenditures Change (Q4 TTM) 18.8 % 40.73 % 1.6 % 1.83 %
Seq. Capital Expenditures Change (Q4 TTM) -7.56 % 17.63 % 2.41 % 42.37 %
Capital Expenditures 5 Year Avg. Change 8.54 % -12.94 % 7.22 % 7.85 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com